BMJ asks NICE to withdraw approval for oseltamivir

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.669, 2013-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The rocky road to the NICE approval of taxanes

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

NICE oseltamivir prophylaxis guidelines realistic?

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

NICE oseltamivir prophylaxis guidelines realistic?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Oseltamivir

By Bardsley-Elliot A. Noble S.

Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. : 851-860

Adis International

Access to resources Recommend Favorite

The UK NICE has released draft guidelines for the use of amantadine, oseltamivir and zanamivir for influenza prophylaxis.

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite